These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 9070849

  • 1. ACE inhibition accelerates endothelial regrowth in vivo: a possible explanation for the benefit observed with ACE inhibitors following arterial injury.
    Van Belle E, Meurice T, Tio FO, Corseaux D, Dupuis B, McFadden EP, Lablanche JM, Bauters C, Bertrand ME.
    Biochem Biophys Res Commun; 1997 Feb 24; 231(3):577-81. PubMed ID: 9070849
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin converting enzyme inhibition prevents proto-oncogene expression in the vascular wall after injury.
    Van Belle E, Bauters C, Wernert N, Delcayre C, McFadden EP, Dupuis B, Lablanche JM, Bertrand ME, Swynghedauw B.
    J Hypertens; 1995 Jan 24; 13(1):105-12. PubMed ID: 7759840
    [Abstract] [Full Text] [Related]

  • 3. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
    Zhuo JL, Froomes P, Casley D, Liu JJ, Murone C, Chai SY, Buxton B, Mendelsohn FA.
    Circulation; 1997 Jul 01; 96(1):174-82. PubMed ID: 9236432
    [Abstract] [Full Text] [Related]

  • 4. High affinity binding sites for Perindopril a new inhibitor of angiotensin-I-converting enzyme (ACE) in the rabbit kidney: possible evidence for localization of ACE in endothelial structures and in glomerular mesangium.
    Morin JP, Moulin B, Borghi H, Fillastre JP.
    Int J Tissue React; 1989 Jul 01; 11(2):81-92. PubMed ID: 2559047
    [Abstract] [Full Text] [Related]

  • 5. Effects of perindopril on angiotensin converting enzyme in tissues of the rat.
    Jackson B, Cubela RB, Johnston CI.
    J Hypertens Suppl; 1988 Dec 01; 6(3):S51-4. PubMed ID: 2852236
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors.
    Johnston CI, Mendelsohn FA, Cubela RB, Jackson B, Kohzuki M, Fabris B.
    J Hypertens Suppl; 1988 Dec 01; 6(3):S17-22. PubMed ID: 2852234
    [Abstract] [Full Text] [Related]

  • 7. Perindopril treatment prevents the loss of endothelial nitric oxide function and development of neo-intima in rabbits.
    Hickey H, Makdissi M, Hyland R, Wilks D, Dusting GJ.
    J Mol Cell Cardiol; 1996 Sep 01; 28(9):1985-94. PubMed ID: 8899557
    [Abstract] [Full Text] [Related]

  • 8. Tissue distribution of angiotensin converting enzyme and its inhibition by perindopril in pregnant rabbit and fetus.
    Moulin B, Morin JP, Seurin-Toutain P, Borghi H, Fillastre JP.
    Int J Tissue React; 1990 Sep 01; 12(5):309-17. PubMed ID: 1967131
    [Abstract] [Full Text] [Related]

  • 9. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
    Zhuo J, Casley D, Murone C, Mendelsohn FA.
    J Cardiovasc Pharmacol; 1997 Mar 01; 29(3):297-310. PubMed ID: 9125666
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
    Kohlstedt K, Brandes RP, Müller-Esterl W, Busse R, Fleming I.
    Circ Res; 2004 Jan 09; 94(1):60-7. PubMed ID: 14615289
    [Abstract] [Full Text] [Related]

  • 11. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr 09; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 12. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 May 09; 48(5):2321-6. PubMed ID: 17460297
    [Abstract] [Full Text] [Related]

  • 13. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.
    Yoshiji H, Kuriyama S, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H.
    Clin Cancer Res; 2001 Apr 09; 7(4):1073-8. PubMed ID: 11309359
    [Abstract] [Full Text] [Related]

  • 14. Impaired skeletal muscle performance in the early stage of cardiac pressure overload in rabbits: beneficial effects of angiotensin-converting enzyme inhibition.
    Coirault C, Langeron O, Lambert F, Blanc FX, Lerebours G, Claude N, Riou B, Chemla D, Lecarpentier Y.
    J Pharmacol Exp Ther; 1999 Oct 09; 291(1):70-5. PubMed ID: 10490888
    [Abstract] [Full Text] [Related]

  • 15. Endothelial function studies in pulmonary vascular disease: determination of angiotensin converting enzyme activity in humans (review).
    Cziráki A, Horváth IG, Papp L.
    Int J Mol Med; 2002 Mar 09; 9(3):317-25. PubMed ID: 11836639
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits.
    Weckler N, Leitzbach D, Kalinowski L, Malinski T, Busch AE, Linz W.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep 09; 4(3):191-6. PubMed ID: 14608526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.